Figure 3From: A one-year prospective study of the safety, tolerability and pharmacokinetics of the highest available dose of paliperidone palmitate in patients with schizophrenia Visual predictive check comparing results from the population PK simulation to the actual observed plasma concentrations. PK-pharmacokinetic. Data included is of 192 patients who received 150 mg eq. paliperidone palmitate till the time of their discontinuation.Back to article page